OptumRx generic pipeline forecast
|
|
|
- Bernice Harrell
- 6 years ago
- Views:
Transcription
1 OptumRx generic pipeline forecast 2018 DAYTRANA methylphenidate Noven Therapeutics Transdermal patch All 2018 NORVIR ritonavir AbbVie Capsule; tablet All 2018 PROVENTIL HFA albuterol sulfate Merck Inhalation All 2018 TRAVATAN Z travoprost Alcon/Novartis Ophthalmic All 2018 ZAVESCA miglustat Actelion Capsule All 2018 SPRIX ketorolac Egalet Intranasal All 2018 TRACLEER bosentan Janssen Tablet All 2018 BETIMOL timolol Oak/Akorn Ophthalmic All 2018 SYPRINE trientine Valeant Capsule All 2018 BYETTA exenatide AstraZeneca Subcutaneous All 2018 FENTORA fentanyl Teva Tablet, buccal All 2018 INVANZ ertapenem Merck Intravenous All 2018 ADVAIR DISKUS fluticasone/salmeterol xinafoate GlaxoSmithKline Inhalation All SAMSCA tolvaptan Otsuka Tablet All 2018 TRISENOX arsenic trioxide Cephalon/Teva Intravenous All 2018 ZYTIGA abiraterone Janssen Tablet All 2018 EPOGEN epoetin alfa Amgen PROCRIT epoetin alfa Janssen Subcutaneous; intravenous Subcutaneous; intravenous All All KALETRA lopinavir/ritonavir AbbVie Tablet All 2018 SUPRENZA phentermine Citius/Akrimax Tablet, orally disintegrating All H GANIRELIX ganirelix acetate Organon/Merck Injection All H ZORTRESS everolimus Novartis Tablet All H WELCHOL colesevelam Daiichi Sankyo LOCOID hydrocortisone butyrate PreCision Dermatology/Valeant FORFIVO XL bupropion IntelGenX/Edgemont Tablet; oral suspension All H Lotion All Q All optum.com/optumrx 1
2 MAKENA hydroxyprogesterone caproate Lumara Health/Amag Pharmaceuticals Intramuscular All SENSIPAR cinacalcet Amgen Tablet All RESTASIS cyclosporine Allergan Ophthalmic All Q NAMENDA XR memantine Allergan All Q NUVARING etonogestrel/ ethinyl estradiol Merck Vaginal ring All ADCIRCA tadalafil Eli Lilly/United Therapeutics Tablet All BOTOX COSMETIC PULMICORT Flexhaler botulinum toxin type A Allergan Injection All budesonide AstraZeneca Inhalation All ABSTRAL fentanyl citrate Sentynl Tablet, sublingual All EMSAM selegiline Somerset/Mylan Transdermal patch All REMODULIN treprostinil United Therapeutics Injection All AMRIX cyclobenzaprine Cephalon All H PROAIR HFA albuterol sulfate Teva Inhalation All H LEVITRA vardenafil GlaxoSmithKline/Bayer Tablet All Q LETAIRIS ambrisentan Gilead Sciences Tablet All Q ACANYA clindamycin/benzoyl peroxide Valeant Gel All AMPYRA dalfampridine Acorda All XENICAL orlistat Roche Capsule All RITUXAN MOVIPREP rituxumab PEG-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid Genentech/Roche/ Biogen Idec Intravenous All Salix/Valeant Oral solution All TOLAK fluorouracil Hill Dermaceuticals Cream All CIALIS tadalafil Eli Lilly Tablet All ALOXI palonosetron Helsinn/Eisai Intravenous All ENBREL etanercept Amgen Subcutaneous All Q NEULASTA pegfilgrastim Amgen Subcutaneous All Q RAPAFLO silodosin Allergan Capsule All Q PYLERA bismuth subcitrate potassium/ metronidazole/ tetracycline Allergan/Aptalis Capsule All Q optum.com/optumrx 2
3 STAXYN vardenafil Bayer Tablet, orally disintegrating All FINACEA azelaic acid Bayer Gel All ASTAGRAF XL tacrolimus Astellas BASAGLAR insulin glargine recombinant Eli Lilly/Boehringer Ingelheim All Subcutaneous All CANASA mesalamine Forest/Allergan Rectal suppository All ELIDEL pimecrolimus Valeant Cream All XOLAIR omalizumab Roche/Genentech Intravenous All CUVPOSA glycopyrrolate Merz Oral solution All 2019 ROZEREM ramelteon Takeda Tablet All 2019 TARCEVA erlotinib OSI Pharma/Genentech/ Pfizer Tablet All 2019 MINIVELLE estradiol Noven Transdermal patch All 2019 OMNARIS ciclesonide Sunovion/Takeda Intranasal All H FORTEO teriparatide Eli Lilly Injection All H HERCEPTIN trastuzumab Genentech/Roche Intravenous All Q BEPREVE bepotastine Bausch & Lomb/Valeant Ophthalmic All LATUDA lurasidone Sunovion Tablet All TEKTURNA aliskiren Novartis Tablet All ZYCLARA imiquimod Medicis Cream All ADVATE antihemophilic factor (recombinant), plasma/albuminfree method Baxalta Intravenous All GILENYA fingolimod Novartis Capsule All KORLYM mifepristone Corcept Tablet All RANEXA ranolazine Gilead All AZASITE azithromycin Akorn Ophthalmic All EMEND fosaprepitant dimeglumine Merck Intravenous All FASLODEX fulvestrant AstraZeneca Intramuscular All BENEFIX coagulation factor IX (recombinant) Pfizer Intravenous All CETROTIDE cetrorelix EMD Serono Subcutaneous All EXJADE deferasirox Novartis Tablet All optum.com/optumrx 3
4 FLECTOR diclofenac epolamine IBSA Institut Biochemique/Pfizer Transdermal patch All VESICARE solifenacin Astellas Tablet All EPANED KIT enalapril Silvergate Oral solution All LEVEMIR insulin detemir recombinant Novo Nordisk Subcutaneous All RESCRIPTOR delavirdine ViiV Healthcare Tablet All FIRAZYR icatibant Shire Subcutaneous All AVASTIN bevacizumab Genentech Intravenous All LYRICA pregabalin Pfizer Capsule; oral solution All STRIANT testosterone Auxilium Tablet All TORISEL temsirolimus Pfizer Injection All THALOMID thalidomide Celgene Capsule All EDLUAR zolpidem Meda/Orexo Tablet, sublingual All MYOBLOC botulinum toxin type B US WorldMeds Intramuscular All CYSTARAN cysteamine hydrochloride Sigma Tau Ophthalmic All JADENU deferasirox Novartis Tablet All VERMOX mebendazole Janssen Tablet, chewable All OSMOPREP sodium biphosphate/sodium phosphate Salix Tablet All TREANDA bendamustine Cephalon/Teva Intravenous 25 mg, 100 mg AMELUZ aminolevulinic acid Biofrontera Gel All DUREZOL difluprednate Alcon/Novartis Ophthalmic All APTENSIO XR methylphenidate Rhodes 2020 All MYCAMINE micafungin Astellas Intravenous All 2020 CIPRODEX ciprofloxacin/ dexamethasone Alcon/Novartis Otic All 2020 NOXAFIL posaconazole Merck Tablet; oral suspension All DALIRESP roflumilast AstraZeneca Tablet All SILENOR doxepin Pernix Tablet All JUXTAPID lomitapide Aegerion/Novelion Capsule All ELIGARD leuprolide QLT/Tolmar Subcutaneous All DELZICOL mesalamine Allergan Capsule, delayedrelease All optum.com/optumrx 4
5 SOMATULINE DEPOT TAYTULLA lanreotide Ipsen Subcutaneous All ethinyl estradiol/ norethindrone/ferrous fumarate Allergan Tablet All MOXEZA moxifloxacin Alcon/Novartis Ophthalmic All APTIVUS tipranavir Boehringer Ingelheim Capsule; oral solution All DEPO-SUBQ PROVERA medroxyprogesterone Pfizer Subcutaneous All CHANTIX varenicline Pfizer Tablet All NYMALIZE nimodipine Arbor Oral solution All DULERA MYDAYIS formoterol fumarate/ mometasone furoate amphetamine/ dextroamphetamine mixture Merck Inhalation All Shire DEXILANT dexlansoprazole Takeda Capsule, delayedrelease All All DENAVIR penciclovir Mylan Cream All LUCENTIS ranibizumab Roche Intravitreal All VELPHORO sucroferric oxyhydroxide Fresenius Tablet, chewable All UCERIS budesonide Valeant + = may launch during the stated date or later All optum.com/optumrx 5
6 optum.com/optumrx The information contained herein is compiled from various sources and is provided for informational purposes only. Due to factors beyond the control of OptumRx, information related to prospective drug launches is subject to change without notice. This information should not be solely relied upon for formulary decision-making purposes. OptumRx specializes in the delivery, clinical management and affordability of prescription medications and consumer health products. We are an Optum company a leading provider of integrated health services. Learn more at optum.com. All Optum trademarks and logos are owned by Optum, Inc. All other brand or product names are trademarks or registered marks of their respective owners. This document contains information that is considered proprietary to OptumRx and should not be reproduced without the express written consent of OptumRx. RxOutlook is published by the OptumRx Clinical Services Department Optum, Inc. All rights reserved. ORX6204B_ optum.com/optumrx 6
OptumRx generic pipeline forecast
OptumRx generic pipeline forecast 2017 DAYTRANA Noven Therapeutics methylphenidate Transdermal patch All 2017 NORVIR AbbVie ritonavir Capsule; tablet All 2017 PROVENTIL HFA Merck albuterol sulfate Inhalation
OptumRx generic pipeline forecast
OptumRx generic pipeline forecast 2017 Daytrana methylphenidate Noven Therapeutics Transdermal patch All 2017+ Epiduo adapalene/benzoyl peroxide Endo Gel All 2017+ Norvir ritonavir AbbVie Capsule; tablet
ESTIMATED LAUNCH DATE* Sensipar cinacalcet Amgen Mar 2018 Endocrine Disorders High. Altoprev lovastatin ER Andrx Mar 2018 High Blood Cholesterol Low
Topicort 0.25% Topical Spray desoximetasone topical spray Taro Mar 2018 Skin Sensipar cinacalcet Amgen Mar 2018 Endocrine Disorders High Altoprev lovastatin ER Andrx Mar 2018 High Blood Cholesterol Ketek
Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary
Notice of Mid-Year s to 2019 Paramount Enhanced Formulary Paramount Elite (HMO) may immediately remove a brand name drug on our List if we are replacing it with a new generic drug that will appear on the
2014 DTC National Advertising Awards Finalists
2014 DTC National Advertising Awards Finalists All Gold, Silver, and Bronze winners will be announced at the DTC National Advertising Awards Dinner on April 23. Each therapeutic category winner from Television,
Memorial Hermann Advantage HMO February 2019 Formulary Addendum
Memorial Hermann Advantage HMO February 2019 Formulary Addendum Changes may have occurred since the printing of your current Memorial Hermann Advantage HMO Formulary. Medications that may have been added
Oregon Health Plan prescription benefit updates
Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save
NEW PATENTED MEDICINES REPORTED TO PMPRB 2011 (UPDATE AS OF NOVEMBER 30, HIGHLIGHTED)
HUMAN DRUGS NEW PATENTED MEDICINES REPORTED TO PMPRB 2011 COMPANY BRAND NAME CHEMICAL NAME DIN THERAPEUTIC USE DATE OF FIRST SALE Abbott Laboratories Limited Norvir 100 mg/tablet ritonavir 02357593 HIV
Aetna Better Health of Illinois Medicaid Formulary Updates
October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary
Health Partners Medicare Prime 2019 Formulary Changes
Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes
Step Therapy Medications
Step Therapy Medications Step Therapy (ST PA ) is an automated form of prior authorization. It encourages the use of therapies that should be tried first, before other treatments are covered, based on
UPMC for You Pharmacy and Therapeutics Committee Meeting July 27, 2010 meeting
1. Call to order: The meeting was called to order at 7:10 a.m. UPMC for You Pharmacy and Therapeutics Committee Meeting July 27, 2010 meeting 2. Review of the minutes: The minutes of the April 6, 2010
3 Tier Formulary Additions
3 Tier Formulary Additions Drug Name Tier Category Management ACCU-CHECK GUIDE ME GLUCOSE METER 3 Diabetic Supplies Step Therapy applies pyridostigmine bromide 60mg/5ml syrup 1 Antimyasthenic Agents New
Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions
Alameda Alliance for Health FORMULARY UPDATE Effective: October 27, 2017. Drugs notated with an * have an undetermined implementation date Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee
Select Inhaled Respiratory Agents
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017
ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG FETZIMA CAPSULE
5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release
5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum.
TRICARE Uniform Formulary. Pre-Authorization Requirements
TRICARE Uniform Formulary Pre-Authorization Requirements The Department of Defense (DoD) requires pre-authorization on select medications. These medications are on the DoD s pre-authorization list because
US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health
US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,
Medication and Dose 10/04/ /05/2016 Total % Change Since 10/2012 ABILIFY 10 MG TABLET $18.76 $ %
Table Comparing NADAC prices for select brand name prescription medications on October 4, 2012 and October 5, 2016 to show how much prices have gone up for these medications. These medications increased
ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019
Step Therapy Date Effective: April 1, 2019 ANTICONVULSANTS APTIOM TABLET 200 MG ORAL APTIOM TABLET 400 MG ORAL APTIOM TABLET 600 MG ORAL APTIOM TABLET 800 MG ORAL BANZEL SUSPENSION 40 MG/ML ORAL BANZEL
ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018
ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG ORAL FETZIMA
J Jubilant Pharma Group, catering to Dosage
DOSAGE FORMULATIONS Jubilant Generics, is one of the business arms of J Jubilant Pharma Group, catering to Dosage Formulations (DF) & Active Pharmaceutical Ingredients (API) business segment across developed
2019 Drug List Negative Changes
2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions
Step Therapy Criteria
ADCIRCA ADCIRCA Coverage will be provided if the member has filled a prescription for sildenafil (at least a 30 day supply within the past 365 ) ELIDEL 76-F ELIDEL Coverage will be provided if the member
ACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
2015 Step Therapy Prior Authorization Medical Necessity Guidelines
Tufts Health Unify 2015 Step Therapy Prior Authorization Medical Necessity Guidelines Effective: 01/01/2015 Updated: 10/01/2015 Tufts Health Plan P.O. Box 9194 Watertown, MA 02471-9194 Phone: 855-393-3154
Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.
Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath. AccuNeb inhalation 0.021% solution: 0.63mg/3mL 3-4 times solution
Prescription benefit updates Individual/small group
Prescription benefit updates Individual/small group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps
Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir
Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires
Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria
ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1 BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least
Health Net Health Plan of Oregon, Inc. Oregon Drugs with a quantity limit Effective January 1, 2015 (Published December 15, 2014)
Health Net Health Plan of Oregon, Inc. Oregon Drugs with a quantity limit Effective January 1, 2015 (Published December 15, 2014) Abstral SL Actonel 35mg Limited to 4 s per month. Actonel 5,30mg adapalene
TABLE OF CONTENTS (Click on a link below to view the section.)
Follow the links below to access the complete formularies for Plans: Health Plan Acne Allergy Allergic Anaphylactic Reaction Allergic Conjunctivitis Allergic Rhinitis Asthma Atopic Dermatitis Behavioral
2017 Formulary Changes Year to Date
2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or
LET S TALK PREVENTION
LET S TALK PREVENTION YOUR NO-COST PRESCRIPTION DRUGS FOR PREVENTIVE CARE Your health plan offers certain preventive service benefits at no cost to you. This means you don t have to pay a copay* or coinsurance,
Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions
Alameda Alliance for Health FORMULARY UPDATE Effective: February 15, 2018. Drugs notated with an * have an undetermined implementation date Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee
The following are J Code requirements
The following are J Code requirements J Codes 20610 Arthrocentesis, aspiration and/or injection; major joint or bursa (eg, shoulder, hip, knee joint, subacromial bursa) A9579 Injection, gadolinium based
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR
How Safe and Innovative Are First-in-Class Drugs Approved by Health Canada: A Cohort Study
RESEARCH PAPER How Safe and Are First-in-Class Drugs Approved by Health Canada: A Cohort Study L innocuité et l aspect innovant des nouvelles classes de médicaments approuvés par Santé Canada : une étude
MDwise Self-Administered Codes for Medical
The following codes are associated with medications that can be self-administered by the patient or a caregiver. As a result, MDwise will transfer coverage of these self-administered medications exclusively
PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION
Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate
Pharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update THIRD QUARTER 2017 Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. P&T Committee Decisions Effective August 15, 2017 Dear Healthcare
Pharmacy Formulary Updates for January 2019
Pharmacy Formulary Updates for January 2019 To offer a pharmacy benefit that is clinically appropriate and cost effective, we constantly review how we cover prescription medications. Periodic adjustments
5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details
5-ASA DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum. 1 ANTIEMETICS
5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release
Updated 11/1/17 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda
TABLE OF CONTENTS 1 Table of Contents 2 Introduction 3 Key Marketed Products
TABLE OF CONTENTS 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Epidemiology 2.2 Symptoms 2.3 Etiology 2.4 Pathophysiology 2.5 Co-morbidities and Complications 2.6 Classification
5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release
5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum.
ACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015
J0129 Injection, abatacept (Orencia ), 10 J0178 Injection, aflibercept (Eylea ), 1 J0256 J0257 J0585 J0586 J0587 J0588 J0597 J0641 J0717 J0800 Injection, alpha 1-proteinase inhibitor, human (Aralast NP,
Step Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet
JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.
ANTI DIABETICS BYDUREON 2 MG SUBCUTANEOUS JANUVIA 25 MG TABLET EXTENDED RELEASE SUSPENSION JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET
First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida
First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida Prasad Peri, Ph.D., Branch Chief, ONDQA, FDA March 19, 2014 1 Topics for discussion Introduction
Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18
Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18 Granite Alliance requires step therapy for certain drugs. This means prior to receiving a drug with a step therapy
Step Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG
PULMONARY ARTERIAL HYPERTENSION AGENTS
Approvable Criteria: PULMONARY ARTERIAL HYPERTENSION AGENTS Brand Name Generic Name Length of Authorization Adcirca tadalafil Calendar Year Adempas riociguat Calendar Year Flolan epoprostenol sodium Calendar
MEDICAID QUANTITY LIMIT DRUG LIST
MEDICAID QUANTITY LIMIT DRUG LIST PH51-R-02162018 Brand Name Generic Name Dosage Form Tier Quantity Limit Details Cambia Diclofenac Potassium PACK Tier 2 QL: 9 per 30 days Fentanyl (12 Mcg/Hr, 25 Mcg/
ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced
ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Below is a list formulary changes for the benefit year 2018. This is not a complete list of drugs covered by the Part D plan. The
Managing the Unmanageable
Managing the Unmanageable Controlling Costs in an Explosive Rx Environment Presented by: Dick Bullard, RPh, SVP Pharmacy Darryl Martin, VP of Sales A Unique Vision of Care Magellan Health is a healthcare
ACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
ACAMPROSATE (CAMPRAL)
ACAMPROSATE (CAMPRAL) ACAMPROSATE CALCIUM Creatinine clearance less than 30 PAGE 1 LAST UPDATED 06/2016 ADALIMUMAB (HUMIRA) HUMIRA, HUMIRA PEDIATRIC CROHN'S, HUMIRA PEN, HUMIRA PEN CROHN'S-UC-HS, HUMIRA
List of Designated High-Cost Drugs
List of Designated High-Cost Drugs UPDATED APRIL 25, 2018 For details on the High-Cost Drug policy, see Section 5.8 of the PharmaCare Policy Manual. Recent updates appear in red. Deletions are listed at
TECHNICAL APPENDIX: A PERSPECTIVE ON PRESCRIPTION DRUG COPAYMENT COUPONS
TECHNICAL APPENDIX: A PERSPECTIVE ON PRESCRIPTION DRUG COPAYMENT COUPONS METHODS FOR DETERMINING COPAY COUPON STATUS The copay coupon information comes from www.internetdrugcoupons.com (IDC). These data
CONTACT POLPHARMA GROUP POLPHARMA B2B
DOSSIER FDFLIST Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM 1. Esomeprazole sodium or injection 40 mg Nexium / AstraZeneca Antiulcerant 2. Omeprazole
2019 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January. This document
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
Clinical Policy: CNS Stimulants Reference Number: CP.PMN.XX Effective Date: Last Review Date: Line of Business: Commercial, Medicaid
Clinical Policy: Reference Number: CP.PMN.XX Effective Date: 03.01.18 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy for important
University System of Georgia Prior Authorization, Step Therapy and Quantity Limit List (Updated 1/1/2016)
University System of Georgia, Step Therapy and Quantity Limit List (Updated 1/1/2016) (PA) Your doctor will need to obtain a prior authorization for the drugs listed below, before your prescription drug
2014 Quantity Limits (QL) Criteria
2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food
Quarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
Pain Oral-Intranasal Fentanyl (Abstral, Actiq, Fentora, Lazanda, Onsolis, Subsys)
Pennsylvania Employees Benefit Trust Fund (PEBTF) and n- Medicare Eligible Retired Employees Health Program (REHP), Step Therapy and Quantity Limit List Your doctor needs to get prior authorization for
Michigan Pharmacy and Therapeutics Committee September 11, Minutes
Michigan Pharmacy and Therapeutics Committee September 11, 2018 Minutes Attendees: Vickie Tutag Lehr, Brian Peltz, Jayne Courts, Rony Foumia, Andrew Mac, Andrew Adair, Margo Farber, David Neff, Brad Uren
Pharmacy Updates Summary
All of the following changes were reviewed and approved by the SFHP Pharmacy & Therapeutics (P&T) Committee on 7/16/2014 Effective date: 8/15/2014 Therapeutic Classes reviewed: Hepatitis C Ophthalmic Prostaglandins
2019 Drug List Negative Changes
2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions
September 2018 Pharmacy & Therapeutics Committee Decisions
UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to UCare (approved drug list). These changes are reviewed based
PERSPECTIVE RXPIPELINE
PERSPECTIVE RX ON THE Understanding changes in the medication market and their impact. EnvisionRx continuously monitors the drug pipeline. As treatment options change, we evaluate and share our perspective
Performance Drug List Change Summary Report Effective (Standard Drug List Reflects Removals)
This report highlights all changes (additions, deletions and removals) to the CVS/caremark Performance Drug List. ADDITIONS: Brand Agents: Aranesp (darbepoetin alfa) Hematologic/ Hematopoietic Growth Factors
Clinical Policy: CNS Stimulants Reference Number: CP.PMN.92 Effective Date: Last Review Date: Line of Business: Commercial, Medicaid
Clinical Policy: Reference Number: CP.PMN.92 Effective Date: 03.01.18 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy for important
Quarterly pharmacy formulary change notice
Provider Bulletin October 2018 Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. The changes listed in the table
Therapeutic Class Indications Effective
Mortar & Pestle A Publication of Walgreens Health Initiatives July 30, 2009 A publication created especially for our clients and associates, delivering up-to-date information about brand-name and generic,
ABILIFY ABILIFY DISCMELT ACTONEL ACTOPLUS MET ACTOPLUS MET XR ACTOS ADCIRCA ADVAIR DISKUS ADVAIR HFA
Quantity Limits Paramount Medicare Formulary 2012 Formulary ID 12112, Version 22. CMS Approved 10-23-2012. ABILIFY Abilify TABS ABILIFY DISCMELT Abilify Discmelt ACTONEL Actonel TABS 150MG Actonel TABS
OHIO MEDICAID PHARMACY COVERAGE
OHIO MEDICAID PHARMACY COVERAGE This information is intended for use by providers to help select the most appropriate cost-effective medication and formulation for their patients. Prescribers should utilize
Pharmacy Updates Summary
All of the following changes were reviewed and approved by the SFHP Pharmacy & Therapeutics (P&T) Committee on 04/15/2015 Effective date: 05/15/2015 Therapeutic Classes reviewed: Testosterone replacement
Alprazolam 0.25mg, 0.5mg, 1mg tablets
Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service
DRUG SCHEDULES REGULATION CHANGES JUNE 2018
DRUG SCHEDULES REGULATION CHANGES JUNE 2018 The following amendments to the Schedules to the Drug Schedules Regulation made under the Pharmacy Operations and Drug Scheduling Act came into effect on June
QUANTITY LIMIT CRITERIA
DRUG CLASS (ADHD) AGENTS BRAND NAME (generic) QUANTITY LIMIT CRITERIA ATTENTION DEFICIT HYPERACTIVITY DISORDER ADDERALL (amphetamine mixture) ADDERALL XR (amphetamine extended-release mixture) ADZENYS
PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION
Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate
Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: Version 26 Updated: 11/1/2016
Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: 16162 Version 26 Updated: 11/1/2016 ANALGESICS acetaminophen w/ codeine (300-15 mg, 300-30 mg, 300-60 mg) acetaminophen w/ codeine soln 120-12
WellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/03/2015.
Quarterly pharmacy formulary change notice
MEDICAID PROVIDER BULLETIN October 2018 The formulary changes listed in the table below were reviewed and approved at the second-quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
Deaths Hospitalizations Company. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Janssen Pharmaceuticals
Takeaways: Diabetes Drug Investigation From: BSardi@aol.com Sent: Mon, Dec 22, 2014 at 10:51 am To: Cc: gemcap2@reagan.com martie.whittekin@verizon.net, katjames008@gmail.com clip_image002.jpg (64.5 KB)
RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)
INFECTIOUS DISEASE ACTIMMUNE INTERFERON GAMMA 1B J9216 ADVATE RAHF PFM ONCOLOGY ORAL AFINITOR EVEROLIMUS J7527 INFECTIOUS DISEASE ALFERON N INTERFERON ALFA N3 J9215 ALPHANATE VWF J7186 ALPHANINE SD J7193
Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements
Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements Effective 7/1/2018 Updated 6/2018 BRAND NAME ANTIDEPRESSANTS APLENZIN
Data Class: Internal. 1 inhaler (30 blisters OR 14 blisters institutional pack) per presciption
To help make the use of prescription drugs safer and more affordable, our plan is now using a Drug Quantity Management program. That is, for certain medications, you can receive an amount to last you a
2018 CareOregon Advantage Part D Formulary Changes
2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD
STEP THERAPY CRITERIA
STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription